The applicant hypothesizes that physiological and pharmacological stimuli induce changes in voltage-gated potassium and calcium channel gene expression that in turn alter myocyte excitability in the heart. Biochemical, immunohistochemical, and electrophysiological experiments are proposed to test hypotheses that; 1) dexamethasone regulates cardiomyocyte voltage-gated K+ and Ca2+ currents in action potentials; 2) dexamethasone induces increases in channel mRNAs and cell-surface channel proteins in cardiomyocytes and in the case of Kv1.5 this will be evident as an increase at the intercalated disc; 3) dexamethasone acts directly on cultured adult cardiomyocytes to alter channel gene expression; and 4) altering the synthesis of a single Kv1 subunit can affect the expression of multiple homomeric and/or heteromeric potassium channels. These studies will determine if hormonal control of K+ and Ca2+ channel expression is a novel mechanism for long-term regulation of cardiac excitability.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055312-04
Application #
6043864
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1996-08-01
Project End
2001-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Hewes, Randall S (2008) The buzz on fly neuronal remodeling. Trends Endocrinol Metab 19:317-23
Grishin, Anatoly; Li, Hui; Levitan, Edwin S et al. (2006) Identification of gamma-aminobutyric acid receptor-interacting factor 1 (TRAK2) as a trafficking factor for the K+ channel Kir2.1. J Biol Chem 281:30104-11
Salvador-Recatala, Vicenta; Kim, Yonjung; Zaks-Makhina, Elena et al. (2006) Voltage-gated k+ channel block by catechol derivatives: defining nonselective and selective pharmacophores. J Pharmacol Exp Ther 319:758-64
Zhou, Chaoming; Ziegler, Chandra; Birder, Lori A et al. (2006) Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA. Circ Res 98:1040-7
Grishin, Anatoly; Ford, Henri; Wang, Jin et al. (2005) Attenuation of apoptosis in enterocytes by blockade of potassium channels. Am J Physiol Gastrointest Liver Physiol 289:G815-21
Zaks-Makhina, Elena; Kim, Yonjung; Aizenman, Elias et al. (2004) Novel neuroprotective K+ channel inhibitor identified by high-throughput screening in yeast. Mol Pharmacol 65:214-9
Hahn, Junghyun; Tse, Tonia E; Levitan, Edwin S (2003) Long-term K+ channel-mediated dampening of dopamine neuron excitability by the antipsychotic drug haloperidol. J Neurosci 23:10859-66
Wang, Lin; Takimoto, Koichi; Levitan, Edwin S (2003) Differential association of the auxiliary subunit Kvbeta2 with Kv1.4 and Kv4.3 K+ channels. FEBS Lett 547:162-4
Pal, Sumon; Hartnett, Karen A; Nerbonne, Jeanne M et al. (2003) Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J Neurosci 23:4798-802
Zhang, T T; Takimoto, K; Stewart, A F et al. (2001) Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ Res 88:476-82

Showing the most recent 10 out of 23 publications